Sickle Cell Disease Comprehensive Care Act

Bill 118 s 5097, also known as the Sickle Cell Disease Comprehensive Care Act, is a piece of legislation introduced in the United States Congress. The purpose of this bill is to improve the care and treatment of individuals with sickle cell disease, a genetic blood disorder that affects red blood cells.

The bill aims to establish a comprehensive care program for individuals with sickle cell disease, which would include access to specialized medical care, education and counseling services, and support for patients and their families. The program would also focus on increasing awareness and understanding of sickle cell disease among healthcare providers and the general public.

Additionally, the bill seeks to improve data collection and research on sickle cell disease, in order to better understand the impact of the disease and develop more effective treatments. It also aims to increase funding for research and treatment programs related to sickle cell disease. Overall, the Sickle Cell Disease Comprehensive Care Act is designed to address the needs of individuals with sickle cell disease and improve their quality of life through better access to care, support, and research.